Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,754 | 28,345 | 0 | 0 | 0 |
| Marketable Securities | 6,696 | 12,691 | 0 | 0 | 0 |
| Receivables | 1,601 | 830 | 0 | 0 | 0 |
| TOTAL | $35,227 | $42,379 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 3,902 | 4,108 | N/A | N/A | N/A |
| Other Non-Current Assets | 4,286 | 2,628 | 0 | 0 | 0 |
| TOTAL | $8,188 | $6,736 | $N/A | $N/A | $N/A |
| Total Assets | $43,415 | $49,115 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,083 | 1,346 | 0 | 0 | 0 |
| Accrued Expenses | 2,358 | 2,953 | 0 | 0 | 0 |
| TOTAL | $22,960 | $11,190 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,519 | 6,891 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 77,167 | 77,151 | 0 | 0 | 0 |
| TOTAL | $81,724 | $86,771 | $N/A | $N/A | $N/A |
| Total Liabilities | $104,684 | $97,961 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,460 | N/A | N/A | N/A | N/A |
| Common Shares | 10 | 10 | 0 | 0 | 0 |
| Retained earnings | -64,262 | -51,339 | 0 | 0 | 0 |
| Other shareholders' equity | -7 | -16 | 0 | 0 | 0 |
| TOTAL | $-61,269 | $-48,846 | $0 | $0 | $0 |
| Total Liabilities And Equity | $43,415 | $49,115 | $0 | $0 | $0 |